Health Sciences Assistant Clinical Professor, Internal Medicine, UCSF School of Medicine
Internal Medicine
Dr. Heather A. Harris, MD
|
|
Give Review
Heather Harris practices Internal Medicine. She went to Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. Heather Harris is also a published physician. She has 56 publication published. The most recent publication is: Is curettage needed for uncomplicated incomplete spontaneous abortion? She is registered with Medicare.
Publications
- Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis (Br J Surg 2012; 99: 761-766).
- A mouse model of androgenetic alopecia.
- Estrogen receptor beta agonism increases survival in experimentally induced sepsis and ameliorates the genomic sepsis signature: a pharmacogenomic study.
- Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.
- Estrogen receptor beta-selective agonists stimulate calcium oscillations in human and mouse embryonic stem cell-derived neurons.
- Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.
- Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.
- Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists.
- Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes.
- Estrogen receptor-beta: recent lessons from in vivo studies.
- WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock.
- Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen rece...
- The unexpected science of estrogen receptor-beta selective agonists: a new class of anti-inflammatory agents?
- Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity.
- ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity.
- Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.
- Structure-based design of estrogen receptor-beta selective ligands.
- Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
- Determination of rat oral bioavailability of soy-derived phytoestrogens using an automated on-column extraction procedure and electrospray tandem mass spectrometry.
- Evaluation of an estrogen receptor-beta agonist in animal models of human disease.
- Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
- Global transcription profiling of estrogen activity: estrogen receptor alpha regulates gene expression in the kidney.
- Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand.
- Estrogen receptors alpha and beta have similar activities in multiple endothelial cell pathways.
- Estrogenic effects of 7alpha-methyl-17alpha-ethynylestradiol: a newly discovered tibolone metabolite.
- The ligand binding profiles of estrogen receptors alpha and beta are species dependent.
- Is curettage needed for uncomplicated incomplete spontaneous abortion?
- Progress and prospects in treating postmenopausal vaginal atrophy.
- Expression of meltrin-alpha mRNA is not restricted to fusagenic cells.
- Preclinical characterization of selective estrogen receptor beta agonists: new insights into their therapeutic potential.
- Synthesis and estrogenic activities of novel 7-thiosubstituted estratriene derivatives.
- Functional properties of a conditionally phenotypic, estrogen-responsive, human osteoblast cell line.
- Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens.
- Regulation of metallothionein II messenger ribonucleic acid measures exogenous estrogen receptor-beta activity in SAOS-2 and LNCaPLN3 cells.
- Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts.
- ERbeta ligands. Part 1: the discovery of ERbeta selective ligands which embrace the 4-hydroxy-biphenyl template.
- Constrained phytoestrogens and analogues as ERbeta selective ligands.
- 7-Substituted 2-phenyl-benzofurans as ER beta selective ligands.
- ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives.
- Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol.
- ERbeta ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor beta-selective ligands.
- ERbeta ligands. Part 5: synthesis and structure-activity relationships of a series of 4''-hydroxyphenyl-aryl-carbaldehyde oxime derivatives.
- An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain.
- Estrogen receptor beta ligands: design and synthesis of new 2-phenyl-isoindole-1,3-diones.
- Development of a mouse model of mammary gland versus uterus tissue selectivity using estrogen- and progesterone-regulated gene markers.
- A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis.
- Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones.
- Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands.
- Development of an early biomarker for the ovarian liability of selective estrogen receptor modulators in rats.
- Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman.
- Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
- Trace LC/MS/MS quantitation of 17beta-estradiol as a biomarker for selective estrogen receptor modulator activity in the rat brain.
- Modulation of responses to stress by estradiol benzoate and selective estrogen receptor agonists.
- A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy.
- ERbeta ligands. Part 4: Synthesis and structure-activity relationships of a series of 2-phenylquinoline derivatives.
Schools
Stanford University School Of Medicine
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
UCSF -
Stanford University School of Medicine
Hospital
-
UCSF Medical Center -
El Camino Hospital -
Stanford Health Care
Helpful Reviews
Similar Doctors
|
|
Dr. Matthew P. White, MD |
|
|
Dr. Douglas R. Murphy-Chutorian, MD |
|
|
Dr. Karen Butterfield, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stuart M. Schlisserman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica Davidson, MD |
|
Dr. Salwan Abiezzi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carolina E. Fasola, MD
This Doctor is OpenDoctor Recommended.
|